Coherus Oncology, Inc.CHRSNASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P38
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-138.51M | -577.7% |
| 2024 | $-20.44M | +88.3% |
| 2023 | $-175.17M | +28.0% |
| 2022 | $-243.16M | -528.0% |
| 2021 | $-38.72M | -126.4% |
| 2020 | $146.91M | +850.4% |
| 2019 | $15.46M | +109.7% |
| 2018 | $-160.06M | +21.9% |
| 2017 | $-204.86M | +20.9% |
| 2016 | $-259.06M | - |